Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04149977 · ClinicalTrials.gov registry record · NA
Blood Flow Restriction Therapy in Lower Limb Extensor Injuries
A NA study of Lower Limb Injury, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 128
- Enrollment target
- 1
- Study location
NCT04149977 is a NA study of Lower Limb Injury that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 128 participants, above the 13-participant average among 3 other Lower Limb Injury trials with a reported enrollment target (885% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04149977, a NA study of Lower Limb Injury, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of the study is to determine the efficacy of blood flow restriction therapy on patients with lower limb extensor injuries by measuring pre and post blood flow restriction therapy strength and muscle mass.
Conditions Studied
Interventions
- BEHAVIORAL Physical Therapy with pressure cuff
- BEHAVIORAL Physical Therapy with placebo pressure cuff
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04149977
The ClinicalTrials.gov registry entry for NCT04149977 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 13-participant average among 3 other Lower Limb Injury trials with a reported enrollment target (885% higher). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lower Limb Injury appearing as the primary indexed condition, and to 2 interventions - of which Physical Therapy with pressure cuff is the first listed.
NCT04149977 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04149977 about?
NCT04149977 is a clinical study titled "Blood Flow Restriction Therapy in Lower Limb Extensor Injuries". The primary objective of the study is to determine the efficacy of blood flow restriction therapy on patients with lower limb extensor injuries by measuring pre and post blood flow restriction therapy strength and muscle mass.
What is the current status of trial NCT04149977?
This trial is currently recruiting. It is a NA study. The enrollment target is 128 participants. The study started on 2021-09-01. Estimated completion is 2026-06-01.
What conditions does trial NCT04149977 study?
This clinical trial studies the following conditions: Lower Limb Injury.
What interventions are being tested in trial NCT04149977?
The interventions under investigation include: Physical Therapy with pressure cuff (BEHAVIORAL), Physical Therapy with placebo pressure cuff (BEHAVIORAL).
Who is sponsoring clinical trial NCT04149977?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04149977 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lower Limb Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.